PCK Reporter

September 28, 2015

Reputation Management

A well-organized Reputation Management Plan is now a required tool in any corporation’s communication portfolio. Here are a few ideas that should go into your Reputation Management Plan.
September 22, 2015

Crafting a Suitable IP Strategy – Tips from the Pros!

Many startups are basing their business plans and valuations on their innovation; patents and industrial designs can be the most valuable asset of the company. One of the best strategies to secure protection for your innovation involves the filing of a self-written provisional patent application. On October 21, beginning at 5 p.m., PCK will be providing a hands-on session in which founders can learn the basics of patents from Andrew Currier.
September 22, 2015

Making a Blurry & Illegible Copy is still Copyright Infringement

Geophysical Service Inc v Antrim Energy Inc, 2015 ABQB 482 - The Alberta Court of Queen’s Bench found copyright infringement even though the copy that was made was blurry and completely unusable.
September 21, 2015

“OUTRIGGER” Trade-mark Expunged for Deviation

Padcon Ltd v Gowling Lafleur Henderson LLP, 2015 FC 943 - Padcon's trade-mark for "THE OUTRIGGER STEAKHOUSE AND BAR" was expunged for lack of use by deviation. It's only use was the inclusion of the term "OUTRIGGER" on restaurant menu items and promotional materials.
September 18, 2015

The ITC Asserts Jurisdiction over Digital Patent Infringement

ClearCorrect Operating LLC, et al v International Trade Commission (No 2014-1527) - An appeal to the Federal Circuit will determine whether the ITC has jurisdiction over digital patent infringement: the ability to block the importation of patent-infringing “articles” if those articles take the form of digital information.
September 16, 2015

FC Finds Novartis Patent Promises a Mechanism of Action, not a Treatment

Novartis Pharmaceuticals Canada Inc v Teva Canada Limited, 2015 FC 770 - Novartis was able to uphold its patent against allegations of invalidity from Teva, but not without the Federal Court making a number of razor thin distinctions between what the patent promised and what it did not.
September 15, 2015

FCA Rejects “Exact Matching” Requirement in PM(NOC) Regulations

Eli Lilly Canada Inc v Canada (Attorney General), 2015 FCA 166 - The FCA rejected the notion adopted by the Federal Court that a higher level of specificity is required to adhere to the Regulations than is required for an element to be claimed as a matter of claim construction, bringing the law in line with Industry Canada proposed amendments.
September 9, 2015

The Word “will” can Indicate a Patent Promise, not an Expectation

AstraZeneca Canada Inc v Apotex Inc, 2015 FCA 158 - The FCA acknowledged that the word “will” often refers to an expectation or goal rather than a promise, but still held that the FC did not err in finding that a promise was made when reading the patent as a whole from the eyes of a skilled reader.
September 8, 2015

Federal Court Revisits Schmeiser Differential Method for Calculating Profits

ADIR v Apotex Inc, 2015 FC 721 - In an accounting of profits case, the FC stated that if a non-infringing alternative is to be considered, it “cannot be what one would have done had one complied with the law”.
September 2, 2015

In Situ Reaction Cannot Avoid AstraZeneca’s Product Claim

AstraZeneca Canada Inc v Apotex Inc, 2015 FC 322 - Claim 1 was worded general enough to capture Apotex’s subcoating layer even though Apotex’s subcoating layer was generated by an in situ chemical reaction, a process that the patentee had not contemplated.